Trending...
- Watchdog Reviews Milestones in Exposing Psychiatric Human Rights Abuses in 2024
- Newly formed Dave Aronberg Law taps Assistant U.S. Attorney Emily M. Walters as Partner
- Globally-renowned scholar Dalia Mogahed Joins Origins Consulting Group as Senior Adviser on Islamophobia
TAMPA, Fla. - AkGlobe -- Juventix Regenerative Medical, a leader in regenerative medicine solutions, proudly announces that its Platelet-Rich Plasma (PRP) technology has been featured in a groundbreaking university-published research study. The study, titled "Platelet-Rich Plasma for Rheumatoid Arthritis: A Case Series", published in the peer-reviewed journal Cureus, underscores the efficacy of Juventix PRP in managing rheumatoid arthritis, showcasing its transformative potential in clinical applications.
The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.
Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:
More on AkGlobe News
Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/
About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.
For more information, visit www.Juventix.com or contact:
More on AkGlobe News
📞 (866) 693-4777
✉️ Email: hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.
The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.
Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:
- 84% platelet recovery, significantly enhancing platelet-derived growth factor (PDGF) concentrations.
- 10x increase in PDGF levels, with treated PRP reaching 10,844 pg/mL compared to 1,536 pg/mL in untreated samples.
- Minimal contamination of red and white blood cells, ensuring safety and reducing inflammatory risks.
- Optimized pH of 7.5, creating an ideal environment for platelet activation and growth factor release.
- Innovative activation methods, including photoactivation and bio-incubation, transforming PRP into PRF for versatile clinical applications.
More on AkGlobe News
- Investor Workshop at Mar-A-Lago, $27 Million for Acquisitions and Drug Treatment of Suicidal Depression: NRx Pharmaceuticals, Inc. (Stock S: NRXP)
- The Best Places to Go in Mexico in 2025
- Nayarit: Mexico's Best-Kept Secret for Fall and Winter Getaways in 2025
- LIB: A master of ingenuity in the field of custom test chambers, unlocking unlimited possibilities!
- PRP Aviation Earns Prestigious "Platinum Cirrus Training Center" Designation
Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/
About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.
For more information, visit www.Juventix.com or contact:
More on AkGlobe News
- Juneau: City Museum closure on January 15
- Cyrus Webb and Conversations Media Group Providing New Opportunities for Authors and Creatives to Shine and Thrive
- Juneau: February 3, 2025 Assembly Meeting: Notice of Public Hearing & Venue Change
- Inframark Acquires Cornerstone Properties, Inc., Expanding Community Management Services in Arizona
- Juneau: Join Huna Totem lease open house meetings on January 22 & 23
📞 (866) 693-4777
✉️ Email: hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.
Source: Juventix Regenerative Medical, LLC
0 Comments
Latest on AkGlobe News
- Preserving Mikaben's Legacy: A Plea For Unity And Respect
- Globally-renowned scholar Dalia Mogahed Joins Origins Consulting Group as Senior Adviser on Islamophobia
- Agreement for $27 Million in Funding for Expanding Clinic Acquisitions and Operations,: NRx Pharmaceuticals, Inc. Stock Symbol: NRXP)
- Author and Speaker El-Hajj Maurice Crawford Shabazz Releases New Book
- Newly formed Dave Aronberg Law taps Assistant U.S. Attorney Emily M. Walters as Partner
- USA Green Card Defends the Green Card Lottery as Vital to Opportunity and Diversity
- Watchdog Reviews Milestones in Exposing Psychiatric Human Rights Abuses in 2024
- The Nashville International Chopin Piano Competition Announces Its Second Edition
- Avoid the Quitter's Day Trap this January 10th by Adopting an Ingenious Method Used by Basketball Legend LeBron James: Wear an "I Promise" Wristband
- The Trends Journal's Top Trends of 2025
- Acmeware and Interlace Health Join Forces to Revolutionize Downtime Solutions
- Banner Year For Special Request Ft Rey T, Hunter, Korrosive and MRE Entertainment LLC
- Cyntexa Joins the ServiceNow Consulting and Implementation Partner Program to Envision, Build, and Deploy Meaningful Experiences
- Juneau: Funding to study a long-term solution to Mendenhall Glacial Lake Outburst Flooding (GLOF) included in the American Relief Act of 2025
- Pawganja Token: Redefining Crypto and Community, One Block at a Time
- Acquisition of Kadima Neuropsychiatry Institute for CNS & Psychedelic Research Planned; New Drug Application for Suicidal Depression Treatment: $NRXP
- Nola Blue Records signs legendary Maria Muldaur and estimable Candice Ivory
- TP Transcription & University of Salford Awarded £290k of UK Government Funding
- CourierDocuments.com Launches to Provide Unbeatable Rates for International Document Delivery
- Introducing the CodyMD Crypto Plan